The genetic alterations in the two canonical growth pathways were the upstream drivers in most of the glioblastoma cases, with only five G7/Other subgroup cases in the Combined cohort (2.7%) showing no detectable PI3K/PTEN pathway alteration. This evidence concerns the gene PTEN and glioblastoma.